Variants in interferon-α pathway genes and response to treatment of chronic hepatitis C

被引：0
|
作者：
O'Brien, Thomas R.
Welzel, Tania M.
Bonkovsky, Herbert L.
Chung, Raymond T.
Naishadham, Deepa
Wright, Elizabeth C.
Chanock, Stephen
Morgan, Timothy R.
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A755 / A756
页数：2
相关论文
共 50 条
  • [21] Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C
    Su, Xiaowen
    Yee, Leland J.
    Im, KyungAh
    Rhodes, Shannon L.
    Tang, YongMing
    Tong, Xiaomei
    Howell, Charles
    Raincharran, Darmendra
    Rosen, Hugo R.
    Taylor, Milton W.
    Liang, T. Jake
    Yang, Huiying
    [J]. JOURNAL OF HEPATOLOGY, 2008, 49 (02) : 184 - 191
  • [22] Tolerability and efficacy of pegylated consensus interferon-α in the treatment of chronic hepatitis C
    Ding, Yan-Hua
    Liu, Bin
    Zhang, Xin
    Sun, Li
    Zhang, Hong
    Luo, Hua
    Sun, Yan-Fu
    Liu, Cheng-Jiao
    Zhang, Qi
    Cao, Yu-Chen
    Chen, Hong
    Niu, Jun-Qi
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (01) : 9 - 16
  • [23] Pericarditis due to interferon-α therapy during treatment for chronic hepatitis C
    Gressens, B
    Gohy, P
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2004, 67 (03): : 301 - 302
  • [24] Unfavourable effects of colchicine in combination with interferon-α in the treatment of chronic hepatitis C
    Angelico, M
    Cepparulo, M
    Barlattani, A
    Liuti, A
    Gentile, S
    Hurtova, M
    Ombres, D
    Guarascio, P
    Rocchi, G
    Angelico, F
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (11) : 1459 - 1467
  • [25] The efficacy of twice-a-day treatment of interferon-β for chronic hepatitis C
    Kakizaki, S
    Takagi, H
    Yamada, T
    Ichikawa, T
    Abe, T
    Sohara, N
    Kosone, T
    Kaneko, M
    Takezawa, J
    Takayama, H
    Nagamine, T
    Mori, M
    [J]. HEPATOLOGY, 1998, 28 (04) : 472A - 472A
  • [26] Effectiveness of leukocyte interferon-α treatment in patients with chronic hepatitis C not responsive to recombinant interferon
    Scotto, G
    Grimaldi, M
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (10) : 2173 - 2176
  • [27] Effectiveness of Leukocyte Interferon-α Treatment in Patients with Chronic Hepatitis C Not Responsive to Recombinant Interferon
    Gaetano Scotto
    Maria Grimaldi
    [J]. Digestive Diseases and Sciences, 1998, 43 : 2173 - 2176
  • [28] The interferon signaling pathway genes as biomarkers of hepatitis C virus disease progression and response to treatment
    Helbig, Karla J.
    Beard, Michael R.
    [J]. BIOMARKERS IN MEDICINE, 2012, 6 (02) : 141 - 150
  • [29] Variants in Interferon-Alpha Pathway Genes and Response to Pegylated Interferon-Alpha2a Plus Ribavirin for Treatment of Chronic Hepatitis C Virus Infection in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
    Welzel, Tania Mara
    Morgan, Timothy R.
    Bonkovsky, Herbert L.
    Naishadham, Deepa
    Pfeiffer, Ruth M.
    Wright, Elizabeth C.
    Hutchinson, Amy A.
    Crenshaw, Andrew T.
    Bashirova, Arman
    Carrington, Mary
    Dotrang, Myhanh
    Sterling, Richard K.
    Lindsay, Karen L.
    Fontana, Robert J.
    Lee, William M.
    Di Bisceglie, Adrian M.
    Ghany, Marc G.
    Gretch, David R.
    Chanock, Stephen J.
    Chung, Raymond T.
    O'Brien, Thomas R.
    [J]. HEPATOLOGY, 2009, 49 (06) : 1847 - 1858
  • [30] Effect of interferon-λ4 on treatment response to peg-interferon-α-2a and ribavirin in patients with chronic hepatitis C
    Staettermayer, Albert
    Hofer, Harald
    Rutter, Karoline
    Beinhardt, Sandra
    Scherzer, Thomas-Matthias
    Steindl-Munda, Petra E.
    Ferenci, Peter
    [J]. HEPATOLOGY, 2013, 58 : 1124A - 1125A
12345